Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Elevation Oncology Inc increased its cash reserves by 7.27%, or 3.34m. Cash Flow from Financing totalled 47.98m or -- of revenues. In addition the company used 56.18m for operations while cash from investing totalled 11.54m.
Cash flow per share | -0.8295 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.48 |
---|---|
Tangible book value per share | 1.48 |
More ▼
Balance sheet in USDView more
Current ratio | 41.10 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.3821 |
---|---|
Total debt/total capital | 0.2765 |
More ▼